Bangladesh Uses Facility Assessment to Expose Weak Points in Medicine Supply Chains
Bangladesh is moving to tighten control over essential medicine supply after a joint field assessment by the Directorate General of Health Services and the World Health Organization examined how medicines are stored, tracked and distributed across public facilities. The review spanned 16 public health facilities and focused on the electronic Logistics Management Information System, or eLMIS, along with storage conditions, inventory management and pharmacy practices.
The exercise matters because essential medicines do not fail patients only when shelves are empty. Failures begin earlier, when demand is misread, stock records drift away from reality, storage conditions erode product quality and reporting systems send contradictory signals to the people responsible for procurement. In that setting, shortages become predictable rather than accidental.
Conducted between 13 September and 5 October 2026, the assessment visited district hospitals and upazila health complexes in Khulna, Sunamganj, Rajshahi, Khagrachari, Bhola and Nilphamari. Teams used a standardized tool to compare medicine stocks with facility records, inspect storage environments and assess how health workers used logistics information to manage supplies. The findings will feed into future efforts to strengthen medicine supply chains and inform possible nationwide expansion of eLMIS.
Stock Visibility Remains the Central Problem
Reliable stock visibility is the foundation of any functioning medicine system. In Bangladesh, the assessment found that routine use of eLMIS was still uneven, with shortages of equipment and trained personnel, parallel manual reporting systems and mismatches between recorded and physical stock. Those weaknesses are more than administrative irritants. When a facility record says one thing and the pharmacy shelf says another, procurement decisions lose precision and the risk of both stockouts and wastage rises sharply.
The system itself is not new. Bangladesh has progressively introduced eLMIS since 2021, extending it to 84 facilities in nine pilot districts, as well as central supply operations and selected disease programmes. The design is straightforward: improve visibility of stock levels, sharpen forecasting and give health authorities the ability to identify potential shortages before patients feel the consequences. In practice, digital reporting only works when staff have the tools, training and time to use it consistently.
Shortages in the public sector carry a familiar downstream cost. Patients are forced to seek medicines elsewhere, often at higher personal expense, while facilities lose the ability to guarantee continuity of treatment. For chronic diseases, maternal care, infectious disease treatment and emergency care alike, interrupted access can alter outcomes long before a clinical complication is documented.
Storage Conditions and Pharmacy Practice Affect Medicine Quality
The assessment also identified inadequate storage conditions and monitoring practices across the visited sites. That finding is clinically important because medicine quality can deteriorate when storage infrastructure fails to protect products from heat, humidity, light or disorganized handling. Even when procurement succeeds, poor storage can turn a delivered medicine into a compromised one.
Good Pharmacy Practices sit at the center of this problem. They are not cosmetic standards; they are the operational rules that preserve potency, reduce wastage and protect patients from avoidable supply failures. Where monitoring is weak, expiries can go unnoticed, damaged stock can remain in circulation and inventory may be reordered too late or in the wrong quantity. In a resource-constrained setting, those losses can ripple across an entire district health system.
Preliminary observations pointed to procurement delays, budget constraints and supply limitations as additional drivers of medicine shortages. The interplay is familiar in public-sector supply chains: financing delays slow purchases, purchasing delays slow delivery, weak inventory systems hide emerging gaps and insufficient storage worsens the impact once products arrive. Each weakness reinforces the next.
Workforce Capacity Will Decide Whether Digital Systems Deliver Results
“Digital systems can help transform the management of essential medicines, but their success depends on the systems and people supporting them,” said Sangay Wangmo, Senior Health Policy Advisor, WHO Bangladesh. The statement reflects the central lesson of the assessment. Software can only show what the workforce is able to record, interpret and act on.
The review found that human capacity remains a limiting factor. In facilities where trained personnel are in short supply, even a well-designed electronic platform can become a second layer of paperwork instead of a decision-support tool. The persistence of both paper-based and electronic reporting increases the workload and invites discrepancies, especially when staff must reconcile two systems under pressure.
Professor Dr. Foara Tasmim, Additional Director General for Planning and Development at DGHS, framed the issue around universal health coverage and access to safe, effective and affordable essential medicines. A supply chain that cannot anticipate demand cannot reliably protect access. A supply chain that cannot respond to stock gaps cannot protect continuity of treatment.
What the Preliminary Recommendations Signal for National Scale-Up
A detailed assessment report is being prepared, but the preliminary recommendations already point toward the practical levers available to policymakers. These include strengthening staff training and supervision, improving storage infrastructure, standardizing medicine lists, addressing procurement constraints and reducing the burden of duplicate paper-based and electronic reporting. The review will also help determine what infrastructure, workforce capacity and institutional support are needed for broader eLMIS implementation.
The central policy question is not whether Bangladesh should digitize medicine logistics. The more immediate issue is how to make digitization dependable at facility level, where shortages, broken workflows and uneven supervision are already embedded in daily practice. If eLMIS expands without addressing those constraints, the system risks reproducing the same supply failures in a more modern format.
By contrast, a functioning logistics platform can expose recurring shortages early enough for procurement teams to act, reduce waste from expired stock and give district facilities a clearer picture of what is available before patients are turned away. The assessment suggests that Bangladesh now has enough pilot experience to see where the weak links are, but the hard work lies in fixing them before expansion.
The next test is operational, not conceptual. Whether national scale-up succeeds will depend on staffing, storage, procurement discipline and the willingness of health facilities to stop running parallel systems that no longer match the scale of the problem.